Clinical impact of tumor location on the colon cancer survival and recurrence: analyses of pooled data from three large phase III randomized clinical trials

Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502

(2015) S. Sadahiro et al.   ANNALS OF ONCOLOGY

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

(2015) S.Y. Brulé et al.   EUROPEAN JOURNAL OF CANCER

Prognostic Comparison Between Mucinous and Nonmucinous Adenocarcinoma in Colorectal Cancer

(2015) Jong Seob Park et al.   MEDICINE

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

(2014) J. C. von Einem et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

(2014) N B Volz et al.   PHARMACOGENOMICS JOURNAL

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer

(2013) M. K. Boisen et al.   ANNALS OF ONCOLOGY

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut)

(2013) Dominik P. Modest et al.   ANTI-CANCER DRUGS

Colorectal cancer

(2013) Hermann Brenner et al.   LANCET

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

(2011) T Yokota et al.   BRITISH JOURNAL OF CANCER

Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival

(2011) Frank Benedix et al.   DISEASES OF THE COLON & RECTUM

Does 1 Year Adjuvant Chemotherapy with Oral 5-FUs in Colon Cancer Reduce the Peak of Recurrence in 1 Year and Provide Long-term OS Benefit?

(2010) C. Hamada et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?

(2008) Robert A. Meguid et al.   ANNALS OF SURGICAL ONCOLOGY

Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology

(2007) Toru Nawa et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY